Anticoagulants
Also known as: blood thinners
Anticoagulants are medications that interfere with the clotting cascade to prevent blood clots from forming or growing. Major examples include heparin, warfarin, and direct oral anticoagulants like apixaban and rivaroxaban.
Anticoagulants — commonly called blood thinners — are drugs that slow the coagulation cascade, the chain of clotting factor reactions that produces fibrin clots. They are used to prevent and treat conditions driven by unwanted clotting, including deep vein thrombosis, pulmonary embolism, and stroke prevention in atrial fibrillation. Importantly, anticoagulants prevent clots from forming or extending; they do not dissolve existing clots (thrombolytics do) and they work differently from antiplatelets like aspirin, which act on platelets rather than clotting factors.
The major classes work at different points in the cascade. Heparin and low-molecular-weight heparins (such as enoxaparin) enhance antithrombin's ability to inactivate thrombin and factor Xa; unfractionated heparin is monitored with the aPTT. Warfarin blocks vitamin K recycling, reducing production of factors II, VII, IX, and X; it is monitored with the PT/INR and interacts with many drugs and vitamin K-containing foods. Direct oral anticoagulants (DOACs) — apixaban, rivaroxaban, and edoxaban (factor Xa inhibitors) and dabigatran (a direct thrombin inhibitor) — provide predictable dosing without routine monitoring.
Because the line between therapeutic effect and dangerous bleeding is thin, anticoagulants are classified as high-alert (high-risk) medications. Warfarin in particular has a narrow therapeutic index. Key safety knowledge includes the reversal agents: protamine sulfate for heparin and vitamin K for warfarin.
Anticoagulants appear on the PTCE among cardiovascular medications, on the NCLEX as high-risk medications requiring careful monitoring, and on the CCMA exam in the context of blood collection, where anticoagulant additives in collection tubes prevent samples from clotting.
Key takeaways
- Anticoagulants interfere with clotting factors to prevent clot formation and extension — they do not dissolve existing clots.
- Heparin works through antithrombin and is monitored with aPTT; protamine sulfate reverses it.
- Warfarin blocks vitamin K-dependent factors (II, VII, IX, X), is monitored with PT/INR, and is reversed with vitamin K.
- DOACs like apixaban, rivaroxaban, and dabigatran offer predictable dosing without routine lab monitoring.
- The PTCE, NCLEX, and CCMA exams all test anticoagulants — as drug class, high-risk medication, and lab additive respectively.